Shumail Fatima, MD, MS, FACP

One of the most important pieces from this guideline is the new Clinical Classes for Acute PE. This new scheme encourages clinicians and researchers to more granuarly define risk profiles for patients with acute PE when determining the best acute intervention plans.

🧵 1/ First ever AHA/ACC/multi-society guidelines re: diagnosis & management of acute PE released today! 2 year effort with 38 authors from 10 specialties. Link attached & summary in this thread: jacc.org/doi/10.1016/j.…

Echo DD guidelines are consensus based and require testing to determine clinical utility. In this multicenter study with gold standard dx, we show poor sensitivity and accuracy for resting and exercise echo criteria. @JACCJournals jacc.org/doi/10.1016/j.…

📌 Which medications should we avoid in HF patients ⁉️ This position 🗞️ provides a very practical guide in daily clinical practice. 📄 A must-read for clinicians caring for HF pts. 🔗 ow.ly/fwQ250XLsZW @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd #EJHF

Check our viewpoint published @JAMA_current #MedEd Abstract Factory—Research Culture Harming Medical Education The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor. ➡️jamanetwork.com/journals/jama/… @utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG

Lots of confusion about menopausal hormone therapy right now —who should get it, when to start, and what is the🫀 risk? Our new review led by @BrighamMedRes Ruby Guo covers timing, route, and CV risk stratification for midlife women. 🔗: rdcu.be/eSUqJ

✨And don't forget to read the thoughtful and insightful editorial by @DrOliviaGilbert @BaracYaron @derek_c1 in @JCFINT discussing this📰. Grateful for their perspective and for advancing this important conversation. 🔗 onlinejcfi.org/article/S3050-… @MattH_MD @GavHick @IbrahimSultanMD

🚨 New Publication Alert! 🚨 Our article, “Cost-effectiveness of CABG vs PCI in Severe ICM,” is now out in @JCFINT ! ✨This🧾clarifies the long-term💰of CABG vs PCI in an area where head-to-head RCTs are lacking. 🔗onlinejcfi.org/article/S3050-… #cardiotwitter #HeartFailure #CABG #PCI

🚨Exciting News🚨 Honored to see our upcoming 🧾on "Cost-effectiveness of CABG vs PCI in Severe ICM" discussed in an insightful and thought-provoking editorial by @DrOliviaGilbert @BaracYaron @derek_c1 in @JCFINT 🔗onlinejcfi.org/article/S3050-… #cardiotwitter #HeartFailure #CABG #PCI

New Residual Risk Score! Now you can calculate almost immediately the 10-year risk of your patient who has prior ASCVD The risk calculator is free online & outperforms existing risk assessment algorithms: jacc.org/doi/abs/10.101…

Nice audience and great questions at our oral presentation titled “repositioning IABP in pts awaiting OHT leads to worse outcomes” today at #HFSA2025. Grateful for the opportunity to present @HFSA & represent @HarringtonHVI

One of the coolest conference stages I’ve seen lately @HFSA #HFSA2025 beings shortly P.S. Do join us at 8:05 am on Sept 28 at oral stage 2 in Exhibit Hall to learn more about our project in an oral presentation @UHCardsFellows @HarringtonHVI @UHhospitals

Symptomatic individuals with no coronary artery calcium but elevated LDL-C have a higher risk of noncalcified plaque and future coronary heart disease events, especially among those aged ≤45 years. Learn more: bit.ly/3JvqEjK #CHD #cvLipids

Finerenone reduced the need for loop diuretic dose intensification and lowered the average loop diuretic dose across all diuretic subgroups in patients with HFmrEF/HFpEF. ja.ma/4meRfzV

🚨 NEW ACC Pericarditis Guidance (2025 CCG) in JACC 🫀 Refines diagnosis & therapy with imaging + immunology front & center: 📌 CMR → central for dx, staging, monitoring inflammation 🔥 IL-1 blockade → preferred 2º in inflammatory recurrences (before steroids) 🧠 Phenotype-based pathways:   • Inflammatory → NSAID + colchicine → IL-1   • Non-inflammatory → steroids, systemic dz workup   • Constrictive → pericardiectomy if refractory 🏥 Refer refractory/complex cases to Pericardial Disease Centers — e.g., @MedStarHealth 🔗 jacc.org/doi/10.1016/j.… #Pericarditis #CMR #IL1 #CardioTwitter @AllanLKleinMD1 @ImazioMassimo

Probably my 3rd or 4th time listening to @payalkohlimd and every time I learn something new @cvinnovations #CVI2025

More interventional heart failure at #CVI2025 @cvinnovations

Learning about hemodynamic monitoring in heart failure at CVI 2025 with the experts in the field: P.S. I found a nice contemporary review of some of the invasive and noninvasive devices currently available jscai.org/article/S2772-… @cvinnovations #CVI2025

South Asian data are absent in #ASCVD risk-derivation cohorts; Tasdighi et al. addressed this notable gap by describing sex-specific coronary artery calcium scores in an exclusively South Asian population. Read an expert analysis for more ➡️ bit.ly/4kQhAmF #cvPrev

Finerenone was effective in heart failure patients with mildly reduced or preserved ejection fraction, regardless of atrial fibrillation (AF) status, and new-onset AF was linked to higher risk of adverse outcomes. ja.ma/44IgNOA @HFpEF @AdriaanVoors @mvaduganathan